Recurrent Superficial Bladder Cancer
Also known as: Superficial, recurrent Bladder Cancer
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12768 | BCG vaccine | A vaccine indicated in the prevention of tuberculosis and the treatment of non-invasive urothelial bladder cancer. |
| DB00445 | Epirubicin | An anthracycline topoisomerase II inhibitor used as an adjuvant to treating axillary node metastases in patients who have undergone surgical resection of primary breast cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00445 | Epirubicin | DNA topoisomerase 2-alpha | target |
| DB00445 | Epirubicin | DNA | target |
| DB00445 | Epirubicin | Multidrug resistance-associated protein 1 | transporter |
| DB00445 | Epirubicin | UDP-glucuronosyltransferase 2B7 | enzyme |
| DB00445 | Epirubicin | Cytosolic phospholipase A2 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|